Clinical Trial Update: Pharmacokinetic of Doripenem and Piperacillin/Tazobactam in More Than 120 kg Critically Ill Patients [NA]

View source ↗

Summary

A completed clinical trial assessing the pharmacokinetics of doripenem and piperacillin/tazobactam in critically ill patients weighing more than 120 kg.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Doribax (doripenem)
• Zosyn (Piperacillin/tazobactam)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Septic Shock | NA | Status: COMPLETED